Search

Your search keyword '"Ola Landgren"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Ola Landgren" Remove constraint Author: "Ola Landgren" Journal blood cancer journal Remove constraint Journal: blood cancer journal
21 results on '"Ola Landgren"'

Search Results

1. Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma

2. Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma

3. Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma

4. Extreme body mass index and survival in newly diagnosed multiple myeloma patients

5. Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

6. Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster

7. Structural variants shape the genomic landscape and clinical outcome of multiple myeloma

8. Nutrition perceptions, needs and practices among patients with plasma cell disorders

10. Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study

11. Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

12. Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

13. Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study

14. Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma

15. Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients

16. Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment

17. Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma

18. Biological determinants of health disparities in multiple myeloma

19. Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey

20. The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies

21. Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

Catalog

Books, media, physical & digital resources